AMANDA WARD: Open Payments
NPI 1316059793 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,322 in 67 payments from 13 companies in 2025. Trend: 2023 $387 · 2024 $1,147 · 2025 $1,322
Food & beverage: $1,322
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $249 |
| LEO Pharma Inc. | 9 | $198 |
| Galderma Laboratories, L.P. | 11 | $193 |
| Novartis Pharmaceuticals Corporation | 8 | $187 |
| Arcutis Biotherapeutics, Inc. | 6 | $122 |
| Janssen Biotech, Inc. | 4 | $81 |
| PFIZER INC. | 5 | $75 |
| GENZYME CORPORATION | 2 | $64 |
| Lilly USA, LLC | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: SKYRIZI, ADBRY, NEMLUVIO, COSENTYX, Zoryve, TREMFYA, CIBINQO, DUPIXENT.
Industry payments across GA — which companies pay providers there.
